128 related articles for article (PubMed ID: 17687170)
1. Inducible nitric oxide synthase expression is upregulated in oral submucous fibrosis.
Rajendran R; Varkey S
Indian J Dent Res; 2007; 18(3):94-100. PubMed ID: 17687170
[TBL] [Abstract][Full Text] [Related]
2. Expression of inducible nitric oxide synthase in human oral premalignant epithelial lesions.
Chen YK; Hsuen SS; Lin LM
Arch Oral Biol; 2002 May; 47(5):387-92. PubMed ID: 12015219
[TBL] [Abstract][Full Text] [Related]
3. Cell death does not herald epithelial involution ("atrophy") in oral sub mucous fibrosis: a TEM study.
Rajendran R; Sunil ; Twinkle SP; Anikumar TV; Annie J
Indian J Dent Res; 2004; 15(1):13-9. PubMed ID: 15682790
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of CD34 for characterization and quantification of mucosal vasculature and its probable role in malignant transformation of atrophic epithelium in oral submucous fibrosis.
Desai RS; Mamatha GS; Khatri MJ; Shetty SJ
Oral Oncol; 2010 Jul; 46(7):553-8. PubMed ID: 20538504
[TBL] [Abstract][Full Text] [Related]
5. Does expression of inducible nitric oxide synthase correlate with severity of oral epithelial dysplasia?
Brennan PA; Palacios-Callender M; Sinclair D; Spedding AV; Zaki GA
J Craniomaxillofac Surg; 2000 Feb; 28(1):44-8. PubMed ID: 10851673
[TBL] [Abstract][Full Text] [Related]
6. Expression of inducible nitric oxide synthase (iNOS) in oral precancer and oral squamous cell carcinoma: an immunohistochemical study.
Varghese SS; Sunil PM; Madhavan RN
Cancer Biomark; 2010-2011; 8(3):155-60. PubMed ID: 22012771
[TBL] [Abstract][Full Text] [Related]
7. [Expression of S100 in oral submucose fibrosis].
Xie XL; Tang ZG; Yao ZG
Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):388-90. PubMed ID: 14653125
[TBL] [Abstract][Full Text] [Related]
8. Epithelial growth fraction and expression of p53 tumour suppressor gene in oral submucous fibrosis.
Cox SC; Walker DM
Aust Dent J; 1996 Apr; 41(2):91-6. PubMed ID: 8670041
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of inducible nitric oxide synthase for human oral submucous fibrosis, verrucous hyperplasia, and verrucous carcinoma.
Chen YK; Hsuen SS; Lin LM
Int J Oral Maxillofac Surg; 2002 Aug; 31(4):419-22. PubMed ID: 12361077
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-1 expression in oral submucous fibrosis: an immunohistochemical study.
Mishra G; Ranganathan K
Indian J Dent Res; 2010; 21(3):320-5. PubMed ID: 20930336
[TBL] [Abstract][Full Text] [Related]
11. Expression of proliferating cell nuclear antigen (PCNA) in oral submucous fibrosis, oral epithelial hyperkeratosis and oral epithelial dysplasia in Taiwan.
Chiang CP; Lang MJ; Liu BY; Wang JT; Leu JS; Hahn LJ; Kuo MY
Oral Oncol; 2000 Jul; 36(4):353-9. PubMed ID: 10899674
[TBL] [Abstract][Full Text] [Related]
12. Expression of inducible nitric oxide synthase and p53 in oral epithelial dysplasia.
Brennan PA; Conroy B; Spedding AV
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Nov; 90(5):624-9. PubMed ID: 11077387
[TBL] [Abstract][Full Text] [Related]
13. Endorsing cellular competitiveness in aberrant epithelium of oral submucous fibrosis progression: neighbourhood analysis of immunohistochemical attributes.
Anura A; Kazi A; Pal M; Paul RR; Sengupta S; Chatterjee J
Histochem Cell Biol; 2018 Jul; 150(1):61-75. PubMed ID: 29687243
[TBL] [Abstract][Full Text] [Related]
14. Increased nitric oxide levels and iNOS over-expression in oral squamous cell carcinoma.
Connelly ST; Macabeo-Ong M; Dekker N; Jordan RC; Schmidt BL
Oral Oncol; 2005 Mar; 41(3):261-7. PubMed ID: 15743688
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of HIF-1alpha in malignant transformation of oral submucous fibrosis.
Tilakaratne WM; Iqbal Z; Teh MT; Ariyawardana A; Pitiyage G; Cruchley A; Stewart JE; Hagi-Pavli E; Lalli A; Waseem A; Parkinson EK; Fortune F
J Oral Pathol Med; 2008 Jul; 37(6):372-7. PubMed ID: 18221327
[TBL] [Abstract][Full Text] [Related]
16. Expression of inducible nitric oxide synthase and heat shock proteins in periapical inflammatory lesions.
Suzuki T; Kumamoto H; Ooya K; Motegi K
J Oral Pathol Med; 2002 Sep; 31(8):488-93. PubMed ID: 12220357
[TBL] [Abstract][Full Text] [Related]
17. Role of angiogenesis in oral submucous fibrosis using vascular endothelial growth factor and CD34: An immunohistochemical study.
Sharma E; Tyagi N; Gupta V; Narwal A; Vij H; Lakhnotra D
Indian J Dent Res; 2019; 30(5):755-762. PubMed ID: 31854369
[TBL] [Abstract][Full Text] [Related]
18. Treatment of oral submucous fibrosis by collagenase: effects on oral opening and eating function.
Lin HJ; Lin JC
Oral Dis; 2007 Jul; 13(4):407-13. PubMed ID: 17577328
[TBL] [Abstract][Full Text] [Related]
19. Morphometric analysis of spinous cell in oral submucous fibrosis. Comparison with normal mucosa, leukoplakia and squamous cell carcinoma.
Gao S; Liu S; Shen Z; Peng L
Chin Med J (Engl); 1995 May; 108(5):351-4. PubMed ID: 7555236
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of human telomerase reverse transcriptase in oral cancer and pre-cancer.
Palani J; Lakshminarayanan V; Kannan R
Indian J Dent Res; 2011; 22(2):362. PubMed ID: 21891916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
